These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6957528)

  • 1. Circulating anticoagulant against factor XI in psoriasis.
    Rustgi RN; LaDuca FM; Tourbaf KD
    J Med; 1982; 13(4):289-301. PubMed ID: 6957528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus-like circulating anticoagulant or antifactor? Preoperative difficult diagnosis].
    Martin-Toutain I; Vu T; Azgui Z; Piot MT; Jung M; Ankri A
    Ann Biol Clin (Paris); 2004; 62(4):451-5. PubMed ID: 15297241
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating factor XI antibody and disseminated intravascular coagulation.
    Fischer DS; Clyne LP
    Arch Intern Med; 1981 Mar; 141(4):515-7. PubMed ID: 7212896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-factor XI circulating anticoagulant (author's transl)].
    Durán Suárez JR; Vilaseca J; Ordeig J; Triginer J
    Sangre (Barc); 1981; 26(5-A):631-7. PubMed ID: 7323919
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired factor XI inhibitor in systemic lupus erythematosus--case report and literature review.
    Bortoli R; Monticielo OA; Chakr RM; Palominos PE; Rohsig LM; Kohem CL; Xavier RM; Brenol JC
    Semin Arthritis Rheum; 2009 Aug; 39(1):61-5. PubMed ID: 18519152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.
    Edwards RL; Rick ME; Wakem CJ
    Arch Intern Med; 1981 Nov; 141(12):1688-90. PubMed ID: 6171218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant after measles.
    Muntean W; Petek W
    Eur J Pediatr; 1980 Aug; 134(2):135-8. PubMed ID: 6777164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occurrence of lupus-type circulating anticoagulant in syphilis (author's transl)].
    Guillaume JC; Gouault-Heilmann M; Dumont MD; Touraine R
    Ann Dermatol Venereol; 1981; 108(2):139-43. PubMed ID: 7247216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.
    Poon MC; Saito H; Koopman WJ
    Blood; 1984 Jun; 63(6):1309-17. PubMed ID: 6426550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM anticoagulant with acquired abnormalities in factor VIII.
    Andes WA
    Thromb Res; 1982 Sep; 27(6):703-12. PubMed ID: 6817451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
    Barrio J; Peris V; Asensio I; Molina I; López F; García V
    Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Report of two cases of circulating anticoagulant directed against factor xi (author's transl)].
    Vila M; Monasterio J; Arangüena PV; Valentin P; Pico M; Triginer J
    Sangre (Barc); 1978; 23(2):202-9. PubMed ID: 653555
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial infarction in a patient with factor XI deficiency and a lupus anticoagulant.
    Humphries JE; Schlein AE; Sarembock IJ; Gonias SL
    Eur Heart J; 1991 Sep; 12(9):1045-7. PubMed ID: 1936005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.
    Castro O; Farber LR; Clyne LP
    Ann Intern Med; 1972 Oct; 77(4):543-8. PubMed ID: 4642734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
    Arai M
    Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired haemophilia in a patient with systemic lupus erythematosus].
    Kornfeld S; Veyssier-Belot C; Vinceneux A; Renier JL; Du-Boutin le TH; Pauwels C
    Ann Dermatol Venereol; 2002 Mar; 129(3):316-9. PubMed ID: 11988689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation inhibitors.
    Corrigan JJ
    Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procoagulant factors and the risk of myocardial infarction in young women.
    Tanis B; Algra A; van der Graaf Y; Helmerhorst F; Rosendaal F
    Eur J Haematol; 2006 Jul; 77(1):67-73. PubMed ID: 16608503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.